THBS2
Thrombospondin-2
Also known as: TSP2, TSP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35442
- Gene
- THBS2
- Ensembl
- ENSG00000186340
- Chromosome
- 6
- Canonical length
- 1172 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Centrosome,Cytosol
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the thrombospondin family. It is a disulfide-linked homotrimeric glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. This protein has been shown to function as a potent inhibitor of tumor growth and angiogenesis. Studies of the mouse counterpart suggest that this protein may modulate the cell surface properties of mesenchymal cells and be involved in cell adhesion and migration. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1172 residues, UniProt reviewed canonical sequence.
>P35442|THBS2
1 MVWRLVLLAL WVWPSTQAGH QDKDTTFDLF SISNINRKTI GAKQFRGPDP GVPAYRFVRF
61 DYIPPVNADD LSKITKIMRQ KEGFFLTAQL KQDGKSRGTL LALEGPGLSQ RQFEIVSNGP
121 ADTLDLTYWI DGTRHVVSLE DVGLADSQWK NVTVQVAGET YSLHVGCDLI DSFALDEPFY
181 EHLQAEKSRM YVAKGSARES HFRGLLQNVH LVFENSVEDI LSKKGCQQGQ GAEINAISEN
241 TETLRLGPHV TTEYVGPSSE RRPEVCERSC EELGNMVQEL SGLHVLVNQL SENLKRVSND
301 NQFLWELIGG PPKTRNMSAC WQDGRFFAEN ETWVVDSCTT CTCKKFKTIC HQITCPPATC
361 ASPSFVEGEC CPSCLHSVDG EEGWSPWAEW TQCSVTCGSG TQQRGRSCDV TSNTCLGPSI
421 QTRACSLSKC DTRIRQDGGW SHWSPWSSCS VTCGVGNITR IRLCNSPVPQ MGGKNCKGSG
481 RETKACQGAP CPIDGRWSPW SPWSACTVTC AGGIRERTRV CNSPEPQYGG KACVGDVQER
541 QMCNKRSCPV DGCLSNPCFP GAQCSSFPDG SWSCGSCPVG FLGNGTHCED LDECALVPDI
601 CFSTSKVPRC VNTQPGFHCL PCPPRYRGNQ PVGVGLEAAK TEKQVCEPEN PCKDKTHNCH
661 KHAECIYLGH FSDPMYKCEC QTGYAGDGLI CGEDSDLDGW PNLNLVCATN ATYHCIKDNC
721 PHLPNSGQED FDKDGIGDAC DDDDDNDGVT DEKDNCQLLF NPRQADYDKD EVGDRCDNCP
781 YVHNPAQIDT DNNGEGDACS VDIDGDDVFN ERDNCPYVYN TDQRDTDGDG VGDHCDNCPL
841 VHNPDQTDVD NDLVGDQCDN NEDIDDDGHQ NNQDNCPYIS NANQADHDRD GQGDACDPDD
901 DNDGVPDDRD NCRLVFNPDQ EDLDGDGRGD ICKDDFDNDN IPDIDDVCPE NNAISETDFR
961 NFQMVPLDPK GTTQIDPNWV IRHQGKELVQ TANSDPGIAV GFDEFGSVDF SGTFYVNTDR
1021 DDDYAGFVFG YQSSSRFYVV MWKQVTQTYW EDQPTRAYGY SGVSLKVVNS TTGTGEHLRN
1081 ALWHTGNTPG QVRTLWHDPR NIGWKDYTAY RWHLTHRPKT GYIRVLVHEG KQVMADSGPI
1141 YDQTYAGGRL GLFVFSQEMV YFSDLKYECR DILocalizationUniProt · AlphaFold · HPA
Whether an antibody against THBS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 160 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 160 nTPM
- gallbladder: 47 nTPM
- ovary: 30 nTPM
- urinary bladder: 27 nTPM
- adipose tissue: 27 nTPM
- endometrium: 26 nTPM
Single-cell type
- somatotrophs: 444 nCPM
- hepatic stellate cells: 303 nCPM
- fibroblasts: 253 nCPM
- epicardial cells: 198 nCPM
- endometrial stromal cells: 115 nCPM
- fibro-adipogenic progenitors: 67 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 57 nTPM
- pons: 56 nTPM
- white matter: 51 nTPM
- midbrain: 51 nTPM
- thalamus: 44 nTPM
- basal ganglia: 44 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about THBS2.
Disease | AllUniProt
Conditions THBS2 is implicated in, by any mechanism.
- Intervertebral disc disease (IDD) MIM:603932
- Ehlers-Danlos syndrome, classic-like, 3 (EDSCLL3) MIM:620865
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 234 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome
- Ehlers-Danlos syndrome, classic-like, 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.56
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Thrombospondin type-1 (TSP1) repeat
- VWFC domain
- EGF-like calcium-binding domain
- Thrombospondin, type 3-like repeat
- Thrombospondin, C-terminal
- Concanavalin A-like lectin/glucanase domain superfamily
- Thrombospondin, type 3 repeat
- NELL2-like, EGF domain
- TSP type-3 repeat
- Thrombospondin type-1 repeat superfamily
- Thrombospondin-like, N-terminal domain
- Thrombospondin type 1 domain
- von Willebrand factor type C domain
- Thrombospondin type 3 repeat
- Thrombospondin C-terminal region
- EGF domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of THBS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THBS2 as an antibody target. Whether an autoantibody or antibody against THBS2 could matter depends on whether native THBS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THBS2 is annotated as secreted, so native THBS2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label THBS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...